BCRG biomedical centre was established in 2015 as a joint project of the Medical Faculty, University of Ostrava and the Hematooncology Department, University Hospital Ostrava. BCRG teams focus on both basic and pre-clinical research with the main aim to develop novel therapeutical approaches in the field of monoclonal gammopathies and other haematological disorders.

Current Events

Latest News

University Hospital Ostrava Awarded G-Rex® Grant to Support CAR-T and CAR-NK Therapy Development
June 16, 2025

Our colleague, MUDr. Mgr. Sandra Charvátová, Ph.D., has been awarded a G-Rex grant to support the development of new cancer immunotherapies. Thanks to this grant, we will be able to use innovative technology for the efficient production of cells that…

Open positions for Ph.D. students and Postdoc researchers
June 16, 2025

Employer: Blood Cancer Research Group, Faculty of Medicine, University of Ostrava, Czech Republic The Immuno-Biophysics Lab within the Blood Cancer Research Group (BCRG) at the Faculty of Medicine, University of Ostrava, is currently seeking…

Research Group Leader in Haematooncology and Cell Therapy
February 15, 2024

Are you a passionate and determined researcher eager to establish your independent research group? We are seeking a curiosity-driven individual to lead fundamental, translational/pre-clinical  research in areas of Molecular Biology, Cell Biology…

Latest Publications

Level of Clonal Plasma Cells in Hematopoietic Cell Autografts Reflects the Pre-Transplant Bone Marrow Minimal Residual Disease in Multiple Myeloma Patients

Impact of T cell characteristics on CAR-T cell therapy in hematological malignancies

Liquid biopsy of peripheral blood using mass spectrometry detects primary extramedullary disease in multiple myeloma patients

Scroll to Top